Evidence map›Paper›PMID 33128653›Full record

ArticleLung2020

Association of Xpert MTB/RIF Cycle Threshold Values with Tuberculosis Treatment Outcomes.

Matheus de Matto Pires, Giovana Rodrigues Pereira, Márcia Silva Barbosa, Natan José Dutra Dias, Carina Secchi, Jociane Saldanha Hoff, Denise Rossato Silva

Abstract read
PubMed Publisher
In one paragraph

Article in Lung, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. The Role of GeneXpertTropical medicine and infectious disease · 2023
    Article
  5. More thanThorax · 2023
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Matheus de Matto PiresPrograma de Pós-Graduação em Ciências Pneumológicas, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
Giovana Rodrigues PereiraPrograma de Pós-Graduação em Ciências Pneumológicas, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
Márcia Silva BarbosaPrograma de Pós-Graduação em Ciências Pneumológicas, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
Natan José Dutra DiasLaboratório Municipal de Alvorada, Alvorada, Brazil.
Carina SecchiLaboratório Municipal de Alvorada, Alvorada, Brazil.
Jociane Saldanha HoffSecretaria Municipal de Saúde, Alvorada, Brazil.
Denise Rossato SilvaPrograma de Pós-Graduação em Ciências Pneumológicas, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. denise.rossato@terra.com.br.ORCID http://orcid.org/0000-0003-0230-2734

Funding

FIPE-HCPA 160063
6 · The paper itself

Abstract

purposeConsidering the current recommendation of the World Health Organization to replace sputum smear microscopy with Xpert MTB/RIF as an initial diagnostic test for tuberculosis (TB), and that culture takes time to provide results, the cycle threshold (C

methodsIn cohort study, Xpert C

resultsDuring this study period, 155 patients (84 cured and 71 non-cured) met the inclusion and were included in the analysis. The mean C

conclusionsLower Xpert MTB/RIF C

Indexed as

AdultAntibiotics, AntitubercularBacterial LoadCohort StudiesFemaleHumansMaleMiddle AgedMycobacterium tuberculosisPolymerase Chain ReactionRifampinSensitivity and SpecificitySputumTreatment OutcomeTuberculosis, Multidrug-ResistantTuberculosis, PulmonaryAntibiotics, AntitubercularRifampinCycle thresholdDiagnosisMolecular testMycobacterium tuberculosisTuberculosisXpert MTB/RIF

Identifiers

PMID33128653

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.